Royal Bank of Canada’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-915,127
| Closed | -$90.9M | – | 7435 |
|
|
2019
Q3 | $90.9M | Sell |
915,127
-160,865
| -15% | -$15.3M | 0.04% | 392 |
|
|
2019
Q2 | $99.5M | Sell |
1,075,992
-98,181
| -8% | -$9.32M | 0.04% | 360 |
|
|
2019
Q1 | $111M | Sell |
1,174,173
-286,964
| -20% | -$25.1M | 0.05% | 321 |
|
|
2018
Q4 | $93.6M | Sell |
1,461,137
-563,359
| -28% | -$41.6M | 0.05% | 344 |
|
|
2018
Q3 | $181M | Buy |
2,024,496
+168,291
| +9% | +$14.9M | 0.08% | 222 |
|
|
2018
Q2 | $147M | Sell |
1,856,205
-887,511
| -32% | -$73.7M | 0.07% | 245 |
|
|
2018
Q1 | $245M | Sell |
2,743,716
-98,704
| -3% | -$9.48M | 0.11% | 161 |
|
|
2017
Q4 | $297M | Buy |
2,842,420
+126,946
| +5% | +$14.3M | 0.13% | 140 |
|
|
2017
Q3 | $396M | Buy |
2,715,474
+111,331
| +4% | +$15.2M | 0.19% | 98 |
|
|
2017
Q2 | $338M | Buy |
2,604,143
+26,547
| +1% | +$3.25M | 0.17% | 109 |
|
|
2017
Q1 | $321M | Sell |
2,577,596
-84,798
| -3% | -$10.1M | 0.17% | 104 |
|
|
2016
Q4 | $308M | Buy |
2,662,394
+8,736
| +0.3% | +$973K | 0.17% | 104 |
|
|
2016
Q3 | $277M | Buy |
2,653,658
+129,371
| +5% | +$14M | 0.16% | 110 |
|
|
2016
Q2 | $249M | Buy |
2,524,287
+298,247
| +13% | +$30.9M | 0.15% | 108 |
|
|
2016
Q1 | $223M | Sell |
2,226,040
-112,139
| -5% | -$11.5M | 0.14% | 112 |
|
|
2015
Q4 | $280M | Buy |
2,338,179
+1,023,600
| +78% | +$118M | 0.18% | 94 |
|
|
2015
Q3 | $142M | Sell |
1,314,579
-35,452
| -3% | -$4.4M | 0.11% | 144 |
|
|
2015
Q2 | $156M | Buy |
1,350,031
+4,704
| +0.3% | +$538K | 0.11% | 143 |
|
|
2015
Q1 | $155M | Sell |
1,345,327
-508,148
| -27% | -$60.7M | 0.11% | 146 |
|
|
2014
Q4 | $207M | Buy |
1,853,475
+243,688
| +15% | +$25.7M | 0.13% | 111 |
|
|
2014
Q3 | $153M | Buy |
1,609,787
+421,039
| +35% | +$38M | 0.1% | 151 |
|
|
2014
Q2 | $102M | Buy |
1,188,748
+573,166
| +93% | +$43.6M | 0.07% | 205 |
|
|
2014
Q1 | $43M | Sell |
615,582
-1,526,388
| -71% | -$121M | 0.03% | 407 |
|
|
2013
Q4 | $181M | Buy |
2,141,970
+413,880
| +24% | +$32.7M | 0.13% | 121 |
|
|
2013
Q3 | $133M | Buy |
1,728,090
+223,202
| +15% | +$15.6M | 0.1% | 136 |
|
|
2013
Q2 | $88M | Buy |
+1,504,888
| New | +$90.6M | 0.07% | 191 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Royal Bank of Canada's CELG Position: Q4 2019 in Review
Royal Bank of Canada sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 915,127 shares — an estimated $90.9M sold.
Royal Bank of Canada first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $396M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Royal Bank of Canada reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Royal Bank of Canada sold 915,127 Celgene Corp shares in Q4 2019, an estimated $90.9M.
- Royal Bank of Canada first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Royal Bank of Canada's Celgene Corp position peaked at $396M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Royal Bank of Canada's 13F filing for Q4 2019, filed 14 Feb 2020.